Spyre Therapeutics ( (SYRE) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Spyre Therapeutics shares are sliding as traders lock in profits and a recent rally loses steam, with the stock pulling back from its 52‑week high and retesting key support levels. The drop is also being driven by signs of market exhaustion after the shares appeared stretched versus short‑term technical indicators.
Adding pressure, the stock was hit with a technical downgrade from “Strong Buy” to “Buy Candidate,” alongside a fresh bearish sell signal from a pivot top flagged earlier in the week. This shift in technical outlook comes even after recent optimism around Spyre’s inflammatory bowel disease pipeline, highlighting how sentiment has turned more cautious in the near term.
More about Spyre Therapeutics
YTD Price Performance: 49.27%
Average Trading Volume: 741,701
Technical Sentiment Signal: Buy
Current Market Cap: $3.84B
For further insights into SYRE stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.